Melanoma survivors: could immunotherapy harm your heart years later?
NCT ID NCT06605833
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 33 times
Summary
This study looks at whether melanoma patients who had immunotherapy (immune checkpoint inhibitors) may have heart problems years later. Researchers will invite 60 people who finished treatment 2 to 10+ years ago to have heart tests. The goal is to see if this kind of long-term monitoring is possible and to plan a larger study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA STAGE III OR IV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Royal Marsden NHS Foundation Trust
London, SW6 3JJ, United Kingdom
Conditions
Explore the condition pages connected to this study.